“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report
August 16, 2023 preprint DOI: 10.31234/osf.io/c9fpj (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report |
|---|---|
| Sample size | 1 |
| Population | 34-year-old autistic woman with aphantasia |
| Intervention | Psilocybin mushrooms |
| Topics | Psilocybin |
| Keywords | Mental image Cognition Affect linguistics Cognitive psychology Autism Developmental psychology Hallucinogen |
| Citations | 2 |
| Key findings | After psilocybin mushroom intake, an autistic woman with aphantasia experienced vivid, manipulable mental imagery that persisted beyond the psychedelic effects. |
Abstract
This retrospective case report explores the impact of psilocybin mushroom intake on the emergence of mental imagery in an autistic woman with aphantasia. Aphantasia refers to the inability to generate visual mental images, which can significantly affect individuals' experiences and cognitive processes. The case study focuses on a 34-year-old autistic woman who had been living with aphantasia since childhood. After consuming psilocybin mushrooms, she reported experiencing vivid mental imagery for the first time, with the ability to manipulate and explore images in her mind. The effects persisted even after the psychedelic effects of psilocybin subsided. The woman's retrospective assessment using the Vividness of Visual Imagery Questionnaire revealed a significant increase in imagery vividness scores post-intake. The findings align with previous research on the effects of psilocybin on brain connectivity, neuroplasticity, and visual processing. The case report highlights the potential of psilocybin to modulate mental imagery in individuals with aphantasia and suggests avenues for further research. Moreover, it raises questions about the classification and pathologization of aphantasia, emphasizing the importance of recognizing cognitive diversity and promoting the well-being of individuals with different cognitive profiles, including aphantasia.
Comparable studies
Other case reports and case series on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man | 1998 | Case study | n = 1 |
| Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain | 2018 | Case study | n = 1 |
| Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication | 2005 | Case study | n = 1 |
| Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain | 2022 | Case series | n = 3 |
| Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder | 2014 | Case study | n = 1 |
Citations in the library
Cited by 1
Cites 23
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Homological scaffolds of brain functional networks Journal of the Royal Society, Interface October 29, 2014
- Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo Neuron July 5, 2021
- Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors Science February 16, 2023
- Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports February 10, 2020
and 18 more in the library